The varicella vaccine. Vaccine development.

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Infectious Disease Clinics of North America

• Publication date

  1996-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0891-5520(05)70309-3PMID 8856348
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Tropism of varicella-zoster virus for human CD4+ and CD8+ T lymphocytes and epidermal cells in SCID-hu mice

  1995cited by this paper
• Restriction fragment length polymorphism of polymerase chain reaction products from vaccine and wild-type varicella-zoster virus isolates

  1992cited by this paper
• Current status and prospects of live varicella vaccine.

  1992cited by this paper
• Differentiation of Oka varicella vaccine strain from wild varicella‐zoster virus strains isolated from vaccinees and household contact

  1991cited by this paper
• The incidence of zoster after immunization with live attenuated varicella vaccine. A study in children with leukemia. Varicella Vaccine Collaborative Study Group.

  1991cited by this paper
• Severity of viremia and clinical findings in children with varicella.

  1990cited by this paper
• A possible role for glycoprotein gpV in the pathogenesis of varicella-zoster virus.

  1990cited by this paper
• A live varicella vaccine.

  1990cited by this paper
• The glycoprotein products of varicella-zoster virus gene 14 and their defective accumulation in a vaccine strain (Oka)

  1990cited by this paper
• The risk of zoster after varicella vaccination in children with leukemia.

  1988cited by this paper
• Clinical Use of Oka Live Varicella Vaccine

  1988cited by this paper
• Specificity of skin test with varicella-zoster virus antigen in varicella-zoster and herpes simplex virus infections

  1987cited by this paper
• Varicella-like illness caused by live varicella vaccine in children with acute lymphocytic leukemia.

  1987cited by this paper
• The complete DNA sequence of varicella-zoster virus.

  1986cited by this paper
• Lymphocyte‐Associated viremia in varicella

  1986cited by this paper
• Clinical overview of varicella vaccine: development and early studies.

  1986cited by this paper
• Clinical experience with Oka live varicella vaccine in Japan.

  1985cited by this paper
• Viremia is present in incubation period in nonimmunocompromised children with varicella.

  1985cited by this paper
• Viral replication and immunologic responses in children naturally infected with varicella-zoster virus and in varicella vaccine recipients.

  1985cited by this paper
• Attenuation and laboratory markers of the Oka-strain varicella-zoster virus.

  1985cited by this paper
• Live varicella vaccine: prevention of nosocomial infection and protection of high risk infants from varicella infection.

  1984cited by this paper
• Seroepidemiologic behavior of varicella zoster virus infection in a semiclosed community after introduction of VZV vaccine.

  1984cited by this paper
• Clinical application of a live varicella vaccine (Oka strain) in a hospital.

  1984cited by this paper
• Chickenpox vaccination of healthy children: immunological and clinical responses and protective effect in 1978-1982.

  1984cited by this paper
• Clinical observations on varicella-zoster vaccinees treated with immunosuppressants for a malignancy.

  1984cited by this paper
• Clinical trial of the Oka strain of live attenuated varicella vaccine on healthy children.

  1984cited by this paper
• Biologic and biophysical markers of a live varicella vaccine strain (Oka): identification of clinical isolates from vaccine recipients.

  1984cited by this paper
• Effect and follow-up study on varicella vaccine.

  1984cited by this paper
• Viremic phase in nonimmunocompromised children with varicella.

  1984cited by this paper
• Varicella-zoster virus-induced transformation of mammalian cells in vitro.

  1984cited by this paper
• A five-year immunological follow-up study of the institutionalized handicapped children vaccinated with live varicella vaccine or infected with natural varicella.

  1984cited by this paper
• Immune response induced by live attenuated varicella vaccine and short term follow-up on immunity of the vaccinated children.

  1984cited by this paper
• Immunization of acute leukemic children with a live varicella vaccine (Oka strain).

  1984cited by this paper
• Varicella infection in a children's hospital: prevention by vaccine and an episode of airborne transmission.

  1984cited by this paper
• Evaluation of varicella vaccine in childhood leukemia. Observation over 6 years.

  1984cited by this paper
• A clinical trial of live attenuated varicella vaccine (Biken) in children with malignant diseases.

  1984cited by this paper
• Use of live varicella vaccine in children with acute leukemia and malignant lymphoma.

  1984cited by this paper
• A live varicella vaccine in a pediatric community.

  1984cited by this paper
• Varicella: clinical manifestations, epidemiology and health impact in children.

  1984cited by this paper
• Chickenpox virus.

  1983cited by this paper
• Detection of Viral Antigens in Formalin‐fixed Specimens by Enzyme Treatment

  1983cited by this paper
• Antibody response to varicella-zoster virus after natural or vaccine-induced infection.

  1982cited by this paper
• Immunologic and epidemiologic aspects of varicella infection acquired during infancy and early childhood.

  1982cited by this paper
• Restriction endonuclease analysis of varicella‐zoster vaccine virus and wild‐type dnas

  1982cited by this paper
• Experimental infection and immune response of guinea pigs with varicella-zoster virus

  1982cited by this paper
• Soluble skin test antigen of varicella-zoster virus prepared from the fluid of infected cultures.

  1981cited by this paper
• Varicella-zoster virus transformation of hamster embryo cells.

  1980cited by this paper
• Application of live varicella vaccine to children with acute leukemia or other malignancies without suspension of anticancer therapy.

  1980cited by this paper
• Humoral and cellular immune response to varicella-zoster virus in children inoculated with live attenuated varicella vaccine.

  1980cited by this paper
• Studies with live varicella vaccine and inactivated skin test antigen: protective effect of the vaccine and clinical application of the skin test.

  1978cited by this paper
• Protective efficacy of vaccination in children in four episodes of natural varicella and zoster in the ward.

  1977cited by this paper
• Diagnostic skin test reactions with varicella virus antigen and clinical application of the test.

  1977cited by this paper
• Application of a live varicella vaccine in children with acute leukemia or other malignant diseases.

  1977cited by this paper
• Protection against varicella in family contacts by immediate inoculation with live varicella vaccine.

  1977cited by this paper
• Clinical and serologic testing of a live varicella vaccine and two-year follow-up for immunity of the vaccinated children.

  1977cited by this paper
• Use of live varicella vaccine in children with acute leukaemia or other malignancies.

  1976cited by this paper
• Live vaccine used to prevent the spread of varicella in children in hospital.

  1974cited by this paper
• The Nature of Herpes Zoster: A Long-Term Study and a New Hypothesis

  1965cited by this paper
• THE ETIOLOGIC AGENTS OF VARICELLA AND HERPES ZOSTER

  1958cited by this paper

• Comparison of human monkeypox, chickenpox and smallpox: a comprehensive review of pathology and dermatological manifestations

  2023cites this paper
• Molecular characterization of varicella zoster virus isolated from clinical samples in India

  2021cites this paper
• Live Attenuated Varicella Vaccine: Prevention of Varicella and of Zoster

  2021cites this paper
• Evaluation of impact of one dose varicella vaccine on the incidence of chickenpox in Argentina.

  2020cites this paper
• Seroconversion and adverse reaction of live-attenuated (OKA strain) varicella vaccine

  2016cites this paper
• [Vaccines against varicella-zoster virus (VZV)].

  2015cites this paper
• Vaccines for post-exposure prophylaxis against varicella (chickenpox) in children and adults.

  2014cites this paper
• Experimental Infection of Cynomolgus Macaques (Macaca fascicularis) with Human Varicella-Zoster Virus

  2012cites this paper
• Evolution and world-wide distribution of varicella-zoster virus clades.

  2011cites this paper
• Immune response of varicella vaccinees to different varicella-zoster virus genotypes.

  2011cites this paper
• Vacunas frente al virus de la varicela zóster

  2008cites this paper
• Generation of a recombinant Oka varicella vaccine expressing mumps virus hemagglutinin-neuraminidase protein as a polyvalent live vaccine.

  2007cites this paper
• Varicella-zoster virus at relapses of multiple sclerosis

  2007cites this paper
• Inmunogenicidad y eficacia protectora de la vacuna de la varicela atenuada y efectividad e impacto de la vacunación universal de la población infantil

  2006cites this paper
• Varicela en el adolescente y adulto: carga de una enfermedad y estrategias de prevención mediante la vacunación

  2005cites this paper
• HAEMOPHILUS INFLUENZAE TYPE B: THE BURDEN IN ASIA

  2004cites this paper
• Viral Vaccine Production in Cell Culture

  2003cites this paper
• Pathogenetic tropism of varicella-zoster virus to primary human hepatocytes and attenuating tropism of Oka varicella vaccine strain to neonatal dermal fibroblasts.

  2003cites this paper
• A comparison of safety, tolerability and immunogenicity of Oka/Merck varicella vaccine and VARILRIX in healthy children.

  2002cites this paper
• Biologic and geographic differences between vaccine and clinical varicella-zoster virus isolates.

  2001cites this paper
• Construction of Oka varicella vaccine expressing human immunodeficiency virus env antigen

  2001cites this paper
• Three year seroepidemiological study of varicella-zoster virus in São Paulo, Brazil.

  2000cites this paper
• The Evolution of Antiviral Therapy for External Ocular Viral Infections Over Twenty-five Years

  2000cites this paper
• Varicella vaccine.

  2000cites this paper
• Varicella-zoster virus eye disease.

  1999cites this paper
• Development of combination vaccines.

  1999cites this paper
• Varicella zoster viral disease.

  1999cites this paper
• Question 4: prvention des infections virus varicelle-zona

  1998cites this paper
• Frontiers of occupational health. New vaccines, new prophylactic regimens, and management of the HIV-infected worker.

  1997cites this paper